Flow cytometric determination of stem/progenitor content in epithelial tissues: An example from nonsmall lung cancer and normal lung

Cytometry Part A

Volumn 83 A, Issue 1, 2013, Pages 141-149

  Donnenberg, Vera S ^a,b,c   Landreneau, Rodney J ^a,b   Pfeifer, Melanie E ^b   Donnenberg, Albert D ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

Author keywords

Collagenase; Flow cytometry data analysis; Lung stem cells; Non small cell lung cancer; Solid tissue

Indexed keywords

BIOLOGICAL MARKER; DNA; KERATIN; STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; METHODOLOGY; PATHOLOGY; STEM CELL;

ADENOCARCINOMA; BIOLOGICAL MARKERS; CARCINOMA, NON-SMALL-CELL LUNG; DNA; DNA, NEOPLASM; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; KERATINS; LUNG; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84871641663     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22156     Document Type: Article

References (46)

1. Ehrlich P. Methodologische Beiträge zur Physiologie und Pathologie der verschiedenen Formen der Leukocyten. Z Klin Med 1879; 1: 5553-5560.
2. Reinherz EL, Kung PC, Goldstein G, Schlossman SF. Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol 1979; 123: 2894-2996.
3. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988; 241: 58-62.
4. Fulwyler MJ. Electronic separation of biological cells by volume. Science 1965; 150: 910-911.
5. Hulett HR, Bonner WA, Barrett J, Herzenberg LA. Cell sorting: automated separation of mammalian cells as a function of intracellular fluorescence. Science 1969; 166: 747-749.
6. Bast RCJr., Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981; 68: 1331-1337.
7. Rabinovitch A, Russell T, Shienvold F, Noel J, Files N, Patel Y, et al. Preparation of rat islet B-cell-enriched fractions by light-scatter flow cytometry. Diabetes 1982; 31: 939-943.
8. Morin O, Patry P, Lafleur L. Heterogeneity of endothelial cells of adult rat liver as resolved by sedimentation velocity and flow cytometry. J Cell Physiol 1984; 119: 327-334.
9. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms. Cancer Cells 1991; 3: 347-350.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988.
11. Zhu H, Mitsuhashi N, Klein A, Barsky LW, Weinberg K, Barr ML, Demetriou A, Wu GD. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 2006; 24: 928-935.
12. Craig W, Kay R, Cutler RL, Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993; 177: 1331-1342.
13. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, Bussolati B, Camussi G. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006; 24: 2840-2850.
14. Zannettino ACW, Paton S, Arthur A, Khor F, Itescu S, Gimble JM, Gronthos S. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cellular Physiol 2008; 214: 413-421.
15. Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K, Thomas K, Austin T, Edwards C, Cuzzourt J, et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anatomical Record 2001; 264: 51-62.
16. Donnenberg VS, Luketich JD, Landreneau RJ, DeLoia JA, Basse P, Donnenberg AD. Tumorigenic epithelial stem cells and their normal counterparts. Ernst Schering Foundation Symp Proc 2006; 5: 245-263.
17. Donnenberg VS, Landreneau RJ, Donnenberg AD. Tumorigenic stem and progenitor cells: Implications for the therapeutic index of anti-cancer agents. J Control Release 2007; 122: 385-391.
18. Yang ZF, Ngai P, Ho DW, Yu WC, Ng MNP, Lau CK, Li MLY, Tam KH, Lam CT, Poon RTP, et al. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008; 47: 919-928.
19. Donnenberg VS, Donnenberg AD, Zimmerlin L, Landreneau RJ, Bhargava R, Wetzel RA, Basse P, Brufsky AM. Localization of CD44 and CD90 positive cells to the invasive front of breast tumors. Cytometry B Clin Cytom 2010; 78B: 287-301.
20. Zimmerlin L, Donnenberg AD, Rubin JP, Basse P, Landreneau RJ, Donnenberg VS. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A 2011; 17(1-2): 93-106.
21. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 1994; 144: 321-328.
22. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998; 11: 728-734.
23. Moore MAS. Converging pathways in leukemogenesis and stem cell self-renewal. Exp Hematol 2005; 33: 719-737.
24. Kajstura J, Rota M, Hall SR, Hosoda T, D'Amario D, Sanada F, Zheng H, Ogorek B, Rondon-Clavo C, Ferreira-Martins J, et al. Evidence for human lung stem cells. N Engl J Med 2011; 364: 1795-1806.
25. Handgretinger R, Gordon PR, Leimig T, Chen X, Buhring HJ, Niethammer D, Kuci S. Biology and plasticity of CD133+ hematopoietic stem cells. Ann N Y Acad Sci 2003; 996: 141-151.
26. Rizzo S, Attard G, Hudson DL. Prostate epithelial stem cells. Cell Proliferation 2005; 38: 363-374.
27. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
28. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106- 110.
29. Maitland NJ, Collins AT. Prostate cancer stem cells: A new target for therapy. J Clin Oncol 2008; 26: 2862-2870.
30. Woo T, Okudela K, Mitsui H, Yazawa T, Ogawa N, Tajiri M, Yamamoto T, Rino Y, Kitamura H, Masuda M. Prognostic value of CD133 expression in stage I lung adenocarcinomas. Int J Clin Exp Pathol 2010; 4: 32-42.
31. Donnenberg VS, Meyer EM, Donnenberg AD. Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells. In: Yu J, editor. Methods in Molecular Biology. Volume 568 Cancer Stem Cells. New York: Humana Press, Springer; 2009. p 261-279.
32. Abeln EC, Corver WE, Kuipers-Dijkshoorn NJ, Fleuren GJ, Cornelisse CJ. Molecular genetic analysis of flow-sorted ovarian tumour cells: Improved detection of loss of heterozygosity. Br J Cancer 1994; 70: 255-262.
33. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011; 472: 90-94.
34. Normolle DP, Donnenberg VS, Donnenberg AD. Statistical classification of multivariate flow cytometric data: An example from non-small lung cancer and normal lung. Cytometry A 2013; 83A: 150-160.
35. Zimmerlin L, Donnenberg VS, Pfeifer ME, Meyer EM, Peault B, Rubin JP, Donnenberg AD. Stromal vascular progenitors in adult human adipose tissue. Cytometry A 2010; 77A: 22-30.
36. Ferry BL, Flannery GR, Robins RA, Lawry J, Baldwin RW. Phenotype of cytotoxic effector cells infiltrating a transplanted, chemically induced rat sarcoma. Immunology 1984; 53: 243-250.
37. Zimmerlin L, Donnenberg VS, Donnenberg AD. Rare event detection and analysis in flow cytometry: Bone marrow mesenchymal stem cells, breast cancer stem/progenitor cells in malignant effusions, and pericytes in disaggregated adipose tissue. In: Hawley TS, Hawley RG, editors. Flow Cytometry Protocols, 3rd ed. Volume 699, Methods in Molecular Biology. New York, N.Y.: Humana Press; 2011.
38. Donnenberg AD, Donnenberg VS. Rare-event analysis in flow cytometry. Clin Lab Med 2007; 27: 627-52, viii.
39. Student [ Gossett WS]. On the error of counting with a haemacytometer. Biometrika 1907; 5: 351-360.
40. Zou H, Hastie T. Regularization and variable selection via the elastic net. J Royal Statist Soc B 2005; 67: 301-320.
41. Breiman L. Random forests. Machine Learn 2001; 45: 5-32.
42. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, MacLaughlin DT, Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 2006; 103: 11154-11159.
43. Engelmann K, Shen H, Finn OJ. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res 2008; 68: 2419-2426.
44. Harris MA, Yang H, Low BE, Mukherje J, Guha A, Bronson RT, Shultz LD, Israel MA, Yun K. Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res 2008; 68: 10051-10059.
45. Dalerba P, Kalisky T, Sahoo D, Rajendran PS, Rothenberg ME, Leyrat AA, Sim S, Okamoto J, Johnston DM, Qian D, et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol 2011; 29: 1120-1127.
46. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.